Abstract:Ploidy changes are frequent in nature and contribute to evolution, functional specialization and tumorigenesis. Analysis of model organisms of different ploidies revealed that increased ploidy leads to an increase in cell and nuclear volume, reduced proliferation, metabolic changes, lower fitness, and increased genomic instability, but the underlying mechanisms remain poorly understood. To investigate how gene expression changes with cellular ploidy, we analyzed isogenic series of budding yeasts from 1N to 4N.… Show more
“…1b ). These results suggest global attenuation of gene and protein expression in the aneuploid clones, consistent with previous studies 3,4,20,23,24 .…”
Section: Resultssupporting
confidence: 92%
“…Therefore, we conclude that both non-transformed and cancerous aneuploid cells suffer from proteotoxic stress and must develop compensatory mechanisms to overcome it. One such mechanism is the reduction of the global translation levels, which may be partly responsible for the protein-level dosage compensation observed in aneuploid cells 3,4,19,20,24 .…”
Aneuploidy, an abnormal chromosome composition, results in a stoichiometric imbalance of protein complexes, which jeopardizes the fitness of aneuploid cells. Aneuploid cells thus need to compensate for the imbalanced DNA levels by regulating their RNA and protein levels, a phenomenon known as dosage compensation. However, the molecular mechanisms involved in dosage compensation in human cells - and whether they can be targeted to selectively kill aneuploid cancer cells - remain unknown. Here, we addressed this question via molecular dissection of multiple diploid vs. aneuploid cell models. Using genomic and functional profiling of a novel isogenic system of RPE1-hTERT cells with various degrees of aneuploidy, we found that aneuploid cells cope with both transcriptional burden and proteotoxic stress. At the mRNA level, aneuploid cells increased RNA synthesis, but concomitantly elevated several RNA degradation pathways, in particular the nonsense-mediated decay (NMD) and the microRNA-mediated mRNA silencing pathways. Consequently, aneuploid cells were more sensitive to the genetic or chemical perturbation of several key components of these RNA degradation pathways. At the protein level, aneuploid cells experienced proteotoxic stress, resulting in reduced translation and increased protein degradation, rendering them more sensitive to proteasome inhibition. These findings were recapitulated across hundreds of human cancer cell lines and primary tumors, confirming that both non-transformed and transformed cells alter their RNA and protein metabolism in order to adapt to the aneuploid state. Our results reveal that aneuploid cells are dependent on the over- or under-activation of several nodes along the gene expression process, identifying these pathways as clinically-actionable vulnerabilities of aneuploid cells.
“…1b ). These results suggest global attenuation of gene and protein expression in the aneuploid clones, consistent with previous studies 3,4,20,23,24 .…”
Section: Resultssupporting
confidence: 92%
“…Therefore, we conclude that both non-transformed and cancerous aneuploid cells suffer from proteotoxic stress and must develop compensatory mechanisms to overcome it. One such mechanism is the reduction of the global translation levels, which may be partly responsible for the protein-level dosage compensation observed in aneuploid cells 3,4,19,20,24 .…”
Aneuploidy, an abnormal chromosome composition, results in a stoichiometric imbalance of protein complexes, which jeopardizes the fitness of aneuploid cells. Aneuploid cells thus need to compensate for the imbalanced DNA levels by regulating their RNA and protein levels, a phenomenon known as dosage compensation. However, the molecular mechanisms involved in dosage compensation in human cells - and whether they can be targeted to selectively kill aneuploid cancer cells - remain unknown. Here, we addressed this question via molecular dissection of multiple diploid vs. aneuploid cell models. Using genomic and functional profiling of a novel isogenic system of RPE1-hTERT cells with various degrees of aneuploidy, we found that aneuploid cells cope with both transcriptional burden and proteotoxic stress. At the mRNA level, aneuploid cells increased RNA synthesis, but concomitantly elevated several RNA degradation pathways, in particular the nonsense-mediated decay (NMD) and the microRNA-mediated mRNA silencing pathways. Consequently, aneuploid cells were more sensitive to the genetic or chemical perturbation of several key components of these RNA degradation pathways. At the protein level, aneuploid cells experienced proteotoxic stress, resulting in reduced translation and increased protein degradation, rendering them more sensitive to proteasome inhibition. These findings were recapitulated across hundreds of human cancer cell lines and primary tumors, confirming that both non-transformed and transformed cells alter their RNA and protein metabolism in order to adapt to the aneuploid state. Our results reveal that aneuploid cells are dependent on the over- or under-activation of several nodes along the gene expression process, identifying these pathways as clinically-actionable vulnerabilities of aneuploid cells.
“…The average DNA content of the left ventricular cardiomyocytes increases about 1.7-fold at this time (Bergmann et al, 2015). We measured the nuclear volume of atrial (A) and ventricular (V) cardiomyocytes in adult human samples (see Methods), as an increase in ploidy levels leads to increases in nuclear volume (Cohen et al, 2018; Galitski et al, 1999; Huber and Gerace, 2007; Storchova et al, 2006; Yahya et al, 2022). Tissue sections of explanted donor hearts from 6 subjects (4 females and 3 males, aged in-between 33 to 44, without any history or pathology of heart diseases) were procured from the Duke Human Heart Repository (DHHR, Fig6A ).…”
Developmentally programmed polyploidy (whole-genome-duplication) of cardiomyocytes is common across evolution. Functions of such polyploidy are essentially unknown. Here, we reveal roles for precise polyploidy levels in cardiac tissue. We highlight a conserved asymmetry in polyploidy level between cardiac chambers in Drosophila larvae and humans. In Drosophila, differential Insulin Receptor (InR)sensitivity leads the heart chamber to reach a higher ploidy/cell size relative to the aorta chamber. Cardiac ploidy-reduced animals exhibit reduced heart chamber size, stroke volume, cardiac output, and acceleration of circulating hemocytes. These Drosophila phenotypes mimic systemic human heart failure. Using human donor hearts, we reveal asymmetry in nuclear volume (ploidy) and insulin signaling between the left ventricle and atrium. Our results identify productive and likely conserved roles for polyploidy in cardiac chambers and suggest precise ploidy levels sculpt many developing tissues. These findings of productive cardiomyocyte polyploidy impact efforts to block developmental polyploidy to improve heart injury recovery.
“…Given that [YAP/TAZ] is not a sole function of cell size, we believe it unlikely that YAP/TAZ size scaling serves to measure cell volume. Indeed, with many hundreds of proteins being shown to scale across cell lines (1, 5,6,11,12), size-scaling behaviour should not be considered sufficient evidence of a size-measurement system. YAP/TAZ are known to be directly regulated by the Hippo signalling pathway, which serves to phosphorylate and sequester YAP/TAZ in the cytoplasm, blunting their transcriptional activity (26,(28)(29)(30)40).…”
Section: Discussionmentioning
confidence: 99%
“…Given that [YAP/TAZ] is not a sole function of cell size, we believe it unlikely that YAP/TAZ size scaling serves to measure cell volume. Indeed, with many hundreds of proteins being shown to scale across cell lines ( 1, 5, 6, 11, 12 ), size-scaling behaviour should not be considered sufficient evidence of a size-measurement system.…”
Protein concentrations are not constant across cell sizes; many dilute or concentrate in response to growth. Through quantitative analysis of ~400,000 single cells across ten cell breast epithelial cell lines (including tumour and non-tumour cells), we show that the cytoplasmic and total concentrations of YAP/TAZ, decreases as a function of cell size in G1 and G2. Degradation of YAP/TAZ alone could not explain this phenomenon. Near S-Phase, YAP/TAZ was synthesised in a ploidy and size dependent manner. Theoretical modelling of YAP/TAZ concentration distributions demonstrated the rate of dilution with cell size relates to YAP/TAZ heterogeneity across the population. YAP/TAZ dilution in the cytoplasm was largely robust to perturbations in Rho GTPase and LATS1/2 signalling, whereas the YAP/TAZ nuclear cytoplasmic (n/c) ratio, was not. Alterations to the n/c ratio following perturbation were more commonly driven by cytoplasmic dilution rather than nuclear enrichment. Together, this work reveals how size scaling phenomena may influence the subcellular distribution of transcription factors, and more generally, relates protein dilution to the emergence of non-genetic heterogeneity in cell populations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.